This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why You Should Hold Molina Healthcare (MOH) in Your Portfolio
by Zacks Equity Research
Molina Healthcare (MOH) remains well-poised for growth on the back of a growing customer base within its Government business. Acquisitions and cost-saving measures also aid the health insurer.
UnitedHealth Group (UNH) Tops Q4 Earnings Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 3.29% and 0%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Centene (CNC) Wins Contract From DHCS to Serve Medi-Cal Members
by Zacks Equity Research
Centene's (CNC) California subsidiary receives a contract from the DHCS to better address the health requirements of the state's Medi-Cal members.
Molina's (MOH) California Medicaid Revenues to Double in 2024
by Zacks Equity Research
Molina Healthcare (MOH) expects combined revenues from California, Nebraska, and Iowa in 2024 to reach $4.2 billion.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Molina Healthcare (MOH) to Incur $200M Impairment Charge in Q4
by Zacks Equity Research
The reduction of Molina Healthcare's (MOH) real estate footprint is expected to result in a sizeable decline in leased real estate expense.
Why Molina (MOH) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Vanguard SmallCap Value ETF (VBR) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VBR
Molina Healthcare (MOH) Up 11% in 6 Months: More Room to Run?
by Zacks Equity Research
Molina Healthcare (MOH) is well-poised for growth on growing premiums, membership increases in Government business and sufficient cash reserves.
Molina (MOH) Down 8.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
by Zacks Equity Research
Sector ETF report for RYH
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RYH
Why Acadia Healthcare (ACHC) Lost 3% Since Q3 Earnings Release
by Zacks Equity Research
Acadia Healthcare's (ACHC) third-quarter results reflect escalating salaries, wages and benefits. The downside was partly mitigated by rising patient admissions within its U.S. facilities.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Tenet Healthcare (THC) Q3 Earnings Beat, Down Y/Y, Shares Drop
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter results reflect a dismal performance of the Hospital Operations and Other segment as well as continued pressure on patient volumes from the pandemic.
Is Molina Healthcare (MOH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Molina (MOH) and Abiomed (ABMD) have performed compared to their sector so far this year.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
5 Stocks to Make the Most of the Halloween Effect
by Tirthankar Chakraborty
With a buying opportunity playing out in the stock market, investing in sound stocks like CalMaine Foods (CALM), Comstock Resources (CRK), Halliburton (HAL), PBF Energy (PBF) and Molina Healthcare (MOH) seems prudent.
Molina Healthcare (MOH) Q3 Earnings Top, 2022 EPS View Up
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results reflect an expanding customer base within its Medicare and Medicaid businesses. Management hikes 2022 adjusted EPS guidance to a minimum of $17.75.
Molina (MOH) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 2.59% and 0.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Philips' (PHG) Q3 Earnings Down on Supply Chain Constraints
by Zacks Equity Research
Koninklijke Philips' (PHG) Q3 top and bottom-line results reflect the negative impact of supply chain constraints, COVID lockdowns in China and the Russia-Ukraine war.
Molina Healthcare (MOH) to Post Q3 Earnings: What to Expect
by Zacks Equity Research
Molina Healthcare's (MOH) Q3 results are expected to reflect better premiums and membership growth in its Medicaid and Medicare businesses, partly offset by steep general and administrative costs.
Should Value Investors Buy Molina Healthcare (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.